Zargis Signs Agreement to Provide Ontario Telemedicine Network With Remote Stethoscope Solution
STAMFORD, Conn., Sept. 10 /PRNewswire/ — Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (OTCQB: SPDE), today announced that it has signed an agreement with the Ontario Telemedicine Network (OTN) providing for the delivery and testing of Zargis’ award-winning telemedicine stethoscope system.
OTN is one of the world’s largest and most respected telemedicine networks. An independent, not-for-profit organization funded by the Government of Ontario, Canada, OTN provides access to care for patients in every hospital in Ontario and hundreds of other healthcare locations across the province. In 2010 OTN will conduct more than 100,000 patient visits over more than 2,000 telemedicine systems.
The core component of Zargis’ telemedicine stethoscope system, Zargis TeleSteth(TM), is a component of the Zargis Cardioscan heart sounds analysis software and the Zargis StethAssistÃ‚® heart and lung sounds visualization software. TeleSteth was developed to extend the practice of auscultation (listening with a stethoscope) to situations and environments where face-to-face encounters are not always convenient or feasible. This platform allows healthcare professionals to share heart, lung and airway sounds with colleagues located across the globe using the Internet or a private network. TeleSteth permits patient sounds to be remotely evaluated in real-time (synchronous) or store-and-forward (asynchronous) mode.
TeleSteth is designed to be accessed from a user’s PC via a standard Internet browser. Additionally, for organizations requiring users to access stethoscope sounds from within their private network, TeleSteth can be deployed using Zargis’ secure enterprise server platform. All components of Zargis’ telemedicine stethoscope system are HIPAA-compliant.
“OTN is one of the world’s most sophisticated telemedicine networks and we are pleased to have been selected as the vendor of tele-auscultation solutions for their vast network of healthcare professionals throughout Canada’s most populous province,” stated Zargis CEO John Kallassy. “Zargis’ tele-auscultation platform will help OTN deliver cost-effective, expert healthcare.”
“OTN depends on reliable and easy-to-use equipment. Zargis’ expertise in the field and the quality of their product met our need for a superior telemedicine stethoscope solution,” said Dr. Ed Brown, OTN’s CEO.
For more information about Zargis’ tele-auscultation tools or to arrange a demonstration, call (609) 488-4608.
About Zargis Medical Corp.
Zargis is a global medical device company focused on improving health outcomes and cost-effectiveness through auscultation software and products. Zargis is majority-owned by Speedus Corp. (OTCQB: SPDE), and both 3M Company and Siemens Corporate Research, a division of Siemens AG (NYSE: SI), hold equity positions.
Statements contained herein that are not historical facts, including but not limited to statements about the Company’s product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company’s sales, marketing and support efforts.
SOURCE Speedus Corp.